OBJECTIVE: To determine whether accounting for the time dynamics of diabetes exposure will change the risk estimates for colorectal cancer. METHODS: We analyzed data from the 45, 516 women enrolled in the BCDDP follow-up cohort study. We used proportional hazards regression to obtain multivariable-adjusted risk estimates for incident colorectal cancer for prevalent diabetes at baseline and diabetes as a time-dependent variable. RESULTS: Subjects with diabetes had a statistically significant increased risk of colorectal cancer compared to subjects without diabetes (RR = 1.60, 95% CI 1.18-2.18). When we defined exposure as duration of diabetes exposure at cohort exit, we found that in the first 4 years after diagnosis risk was essentially the same as in those never having had a diagnosis of diabetes. For those who had been diagnosed between 4 and 8 years previously, however, we observed a RR of 2.36 (95% CI 0.96-5.79), while longer duration of exposure was associated with smaller and then no change in risk compared to those without a diagnosis of diabetes. CONCLUSIONS: These results are consistent with the theory that hyperinsulinemia can explain, at least in part, the association of diabetes with colorectal cancer, but in a time-dependent manner.
OBJECTIVE: To determine whether accounting for the time dynamics of diabetes exposure will change the risk estimates for colorectal cancer. METHODS: We analyzed data from the 45, 516 women enrolled in the BCDDP follow-up cohort study. We used proportional hazards regression to obtain multivariable-adjusted risk estimates for incident colorectal cancer for prevalent diabetes at baseline and diabetes as a time-dependent variable. RESULTS: Subjects with diabetes had a statistically significant increased risk of colorectal cancer compared to subjects without diabetes (RR = 1.60, 95% CI 1.18-2.18). When we defined exposure as duration of diabetes exposure at cohort exit, we found that in the first 4 years after diagnosis risk was essentially the same as in those never having had a diagnosis of diabetes. For those who had been diagnosed between 4 and 8 years previously, however, we observed a RR of 2.36 (95% CI 0.96-5.79), while longer duration of exposure was associated with smaller and then no change in risk compared to those without a diagnosis of diabetes. CONCLUSIONS: These results are consistent with the theory that hyperinsulinemia can explain, at least in part, the association of diabetes with colorectal cancer, but in a time-dependent manner.
Authors: Andrew Flood; Ellen M Velie; Nilanjan Chaterjee; Amy F Subar; Frances E Thompson; James V Lacey; Catherine Schairer; Rebecca Troisi; Arthur Schatzkin Journal: Am J Clin Nutr Date: 2002-05 Impact factor: 7.045
Authors: Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun Journal: Am J Epidemiol Date: 2004-06-15 Impact factor: 4.897
Authors: Sharon H Saydah; Elizabeth A Platz; Nader Rifai; Michael N Pollak; Frederick L Brancati; Kathy J Helzlsouer Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-05 Impact factor: 4.254
Authors: Kay-Tee Khaw; Nicholas Wareham; Sheila Bingham; Robert Luben; Ailsa Welch; Nicholas Day Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-06 Impact factor: 4.254
Authors: James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson Journal: Prog Community Health Partnersh Date: 2015
Authors: Yaritza Díaz-Algorri; María Eugenia Lozada; Sofía M López; Carlos E Bertrán-Rodríguez; Cinthia M González-Hernández; Dilka González; Cynthia M Pérez-Cardona; Jessica Hernández; Carmen Pedrosa; Doris H Toro; María González-Pons; Marcia Cruz-Correa Journal: J Diabetes Complications Date: 2015-02-03 Impact factor: 2.852
Authors: Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi Journal: Cancer Causes Control Date: 2012-05-03 Impact factor: 2.506
Authors: Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Alexander Kulminski; Anatoliy I Yashin Journal: Exp Gerontol Date: 2013-09-21 Impact factor: 4.032